Products for Research Use Only
RegisterLogin

VPC-3033

CAT: 0804-HY-118409Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-118409Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
VPC-3033 is an androgen receptor antagonist. VPC-3033 has a strong androgen DHT replacement potency (IC50: 0.625-2.5 μM), can effectively inhibit androgen receptor transcriptional activity (IC50=0.3 μM), and has a strong androgen receptor degradation ability. In addition, VPC-3033 exhibits significant anti-androgen receptor activity against prostate cancer cells resistant to Enzalutamide.
CAS Number
110763-24-1
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/vpc-3033.html
Smiles
O=C1C2=C(/C(C3=C1C=CC=C3)=C\C4=CC(O)=CC=C4)C=CC=C2
Molecular Formula
C21H14O2
Molecular Weight
298.33
References & Citations
[1]Li H, et al. Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancer[J]. Molecular cancer therapeutics, 2013, 12 (11) : 2425-2435.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-110112-01BTT-3033
HY-122234-01VPC-18005
HY-116501-01VPC-14449
HY-139970VPC-13789
HY-126076A-01VPC-80051
HY-117669-01VPC-14228
HY-147291-01VPC-70063
HY-144878-01VPC-70619
HY-108490-01VPC 23019
HY-120018-01VPC-13566

Alternative Products

CatalogName
T26323-01VPC-3033
JAC02899-01BTT 3033
T26917-01BTT-3033
A17200-25BTT-3033 25mg
A17200-5BTT-3033 5mg
A17200-10BTT-3033 10mg
M28514-01VPC-18005
BA9196-10VPC-13566
BA9177-5.1VPC-14449
BA9202-5VPC-14228

Popular Products